Abiopharma

🔍 CAUSEY CHRISTOPHER (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 1,000 shares of Common Stock at $119.76 per share (Direct)
  Date: 2026-01-02 | Code: M | equity_swap_involved: false | shares_owned_after: 5,190.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,000 shares of Common Stock at $500.0146 per share (Direct)
  Date: 2026-01-02 | Code: S | equity_swap_involved: false | shares_owned_after: 4,190.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,000 shares of Stock Option at $119.76 per share (Derivative)
  Date: 2026-01-02 | Code: M | Expires: 2030-06-26 | Exercise: 2021-06-26 | equity_swap_involved: false | shares_owned_after: 8,320.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.
• F2: This transaction was executed in multiple trades at prices ranging from $500.00 to $500.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.